SCHEMBL2564768

SCHEMBL2564768

CCOC(=O)c1[nH]ccc1N=C=S

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM6 O15303 1/20 0.41
KDM4E B2RXH2 4/20 0.39
KMT2A Q03164 1/20 0.39
NUDT1 P36639 1/20 0.39
HPGD P15428 5/20 0.39
ALDH1A1 P00352 5/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TSHR P16473 1/20 0.38
RAB9A P51151 3/20 0.37
NPC1 O15118 2/20 0.37
MAPT P10636 2/20 0.37
GAA P10253 2/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA7 P43166 2/20 0.36
CA9 Q16790 2/20 0.36
CA14 Q9ULX7 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2575212 0.77 KMT2A (0.48) GRM6KDM4EKMT2ANUDT1HPGD
SCHEMBL2572855 0.77 ALDH1A1 (0.44) GRM6KDM4EKMT2AHPGDALDH1A1
SCHEMBL1457077 0.76 TSHR (0.61) GRM6KDM4EKMT2AALDH1A1CYP1A2
SCHEMBL3736658 0.74 ALDH1A1 (0.49) KDM4EKMT2ANUDT1ALDH1A1TSHR
SCHEMBL13560529 0.74 ALDH1A1 (0.49) KDM4EKMT2ANUDT1ALDH1A1TSHR
SCHEMBL1149707 0.74 KDM4E (0.47) KDM4EKMT2ANUDT1HPGDALDH1A1
SCHEMBL2565889 0.73 KDM4E (0.39) GRM6KDM4EKMT2AHPGDALDH1A1
SCHEMBL16236949 0.73 KDM4E (0.46) KDM4EKMT2ANUDT1HPGDALDH1A1
SCHEMBL6778868 0.73 CA12 (0.52) KDM4EKMT2ANUDT1HPGDALDH1A1
Hydrochloric Acid SCHEMBL2117780 0.73 KDM4E (0.46) KDM4EKMT2ANUDT1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2382218-A1 DELTA-5-DESATURASE INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2011-11-02 EP disclosed
WO-2010087467-A1 DELTA-5-DESATURASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-05 WO disclosed
US-20100190747-A1 Fused ring compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190747-A1 Fused ring compound and use thereof CYP46A1, LTB4R2, PTGES GRM6 3117/4885KDM4E 2686/4885KMT2A 2107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.